CSHP Banff Seminars

🌟Sponsored Symposium by Fresenius Kabi 🌟

📅Register today for the CSHP Banff Seminar 2026!
In-person registration closes: February 25, 2026
Virtual registration closes: March 11, 2026
👉 Link : https://reg.eventmobi.com/cshp-banff-seminar-2026


With more than two decades of progressive leadership in hospital and health-system pharmacy in a more than 30-year hospital pharmacy career, Dr. Patrick Robertson brings expertise in pharmacy operations, healthcare strategy, system integration, and clinical quality improvement.

Upon completion of this session, participants will be able to:
1. Describe the major regulatory, policy, and geopolitical developments anticipated by 2026 that may influence hospital pharmacy practice and operations in Canada.
2. Evaluate the potential impacts of these developments on medication supply management, workforce capacity, and pharmacy service delivery within hospital settings.
3. Analyze emerging practice model changes, including workforce role evolution, automation, and technology integration, and their implications for hospital pharmacy operations.
4. Incorporate forecasted trends into strategic and operational planning to support proactive decision-making and risk mitigation in hospital pharmacy practice.

Pre-registration required for lunch: All attendees have received an RSVP link via email. Please register before Thursday, February 26, 2026 23:59 MS

🌟 Educational Session Spotlight: Mark St. Marie CIH, RCP-SCF 🌟

📅Register today for the CSHP Banff Seminar 2026!
In-person registration closes: February 25, 2026
👉 Link: https://reg.eventmobi.com/cshp-banff-seminar-2026


Mark is a nationally recognized Industrial Hygiene and healthcare environment safety expert with more than 30 years of experience across the U.S. Department of Defense, Federal Government, and private sector. Based in Avon, Indiana, he currently serves as the National Technical Lead – Healthcare at The Vertex Companies, where he supports compliance and technical guidance in healthcare, laboratory, and manufacturing settings. Mark previously led national program initiatives as the Department of Veterans Affairs’ Industrial Hygiene Program Manager, overseeing policy implementation and compliance across more than 175 medical centers. He also served as Director of Strategic Business Development for the 26 Eurofins Built Environment Testing Laboratories in the U.S. A retired U.S. Air Force Bioenvironmental Engineering professional, Mark has an extensive background in training and workforce development, including as an instructor at the USAF School of Aerospace Medicine and as an Adjunct Instructor for sterile compounding facility certification at the Eagleson Institute. He holds a B.A. in Biochemistry from Rhode Island College and is credentialed as a Certified Industrial Hygienist (CIH) and a CETA CNBT Registered Certification Professional for Sterile Compounding Facilities(RCP-SCF). Mark remains active in advancing professional standards through his involvement with AIHA,CETA, ASHRAE, and AAMI.

🌟 Educational Session Spotlight: Amy Wiebe, BSP, MBA, ACPR 🌟

📅Register today for the CSHP Banff Seminar 2026!
Early bird deadline: January 12, 2026
👉 Link: https://reg.eventmobi.com/cshp-banff-seminar-2026



Amy Wiebe is a pharmacist with over 15 years of experience, primarily in hospital settings in Saskatoon. She transitioned into a full-time role as Chief Editor with RxFiles in 2025, while she continues to work casually for the pharmacy department at the Yorkton Regional Health Centre in the Saskatchewan Health Authority. In 2023–2024, Amy completed an Addiction Pharmacy Fellowship through the BC Centre on Substance Use. Her current work focuses on delivering evidence-based drug information, with particular interest in the areas of pain management and substance use.

Alcohol withdrawal syndrome (AWS) is a common and serious condition encountered in hospital practice, often requiring timely and effective management to prevent complications. While benzodiazepines remain the standard of care, phenobarbital has emerged as an alternative or adjunct option in certain scenarios. This session will provide hospital pharmacists with an overview of the pharmacologic rationale for phenobarbital use, summarize the current evidence base, and discuss practical considerations for safe implementation in acute care settings.